Updates in Deposition Arthritis Other Than Gout

This article focuses on updates in calcium pyrophosphate deposition disease (CPPD) and basic calcium phosphate deposition (BCPD), highlighting recent advances in imaging and the understanding of these conditions. It explores their clinical presentations, crystal formation mechanisms, and diagnostic challenges. CPPD and BCPD are often underrecognized causes of arthritis, and recent imaging diagnostic criteria are presented.

Keywords

crystal arthropathy - calcium pyrophosphate deposition - basic calcium phosphate deposition - basic calcium phosphate deposition - calcific tendinosis

Full Text

References

References
1 McCarthy GM. Calcium pyrophosphate and basic calcium phosphate deposition diseases: the year in review 2022. GUCDD 2023; 1 (04) 234-242
2 Mandl P, D'Agostino MA, Navarro-Compán V. et al. 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice. Ann Rheum Dis 2024; 83 (06) 752-759
3 Pascart T, Filippou G, Lioté F, Sirotti S, Jauffret C, Abhishek A. Calcium pyrophosphate deposition disease. Lancet Rheumatol 2024; 6 (11) e791-e804
4 Zhang W, Doherty M, Bardin T. et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 2011; 70 (04) 563-570
5 McCarthy GM, Dunne A. Calcium crystal deposition diseases—beyond gout. Nat Rev Rheumatol 2018; 14 (10) 592-602
6 Richette P, Bardin T, Doherty M. An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. Rheumatology (Oxford) 2009; 48 (07) 711-715
7 Zhang Y, Terkeltaub R, Nevitt M. et al. Lower prevalence of chondrocalcinosis in Chinese subjects in Beijing than in white subjects in the United States: the Beijing Osteoarthritis Study. Arthritis Rheum 2006; 54 (11) 3508-3512
8 Derfus BA, Kurian JB, Butler JJ. et al. The high prevalence of pathologic calcium crystals in pre-operative knees. J Rheumatol 2002; 29 (03) 570-574
9 Steinbach LS. Calcium pyrophosphate dihydrate and calcium hydroxyapatite crystal deposition diseases: imaging perspectives. Radiol Clin North Am 2004; 42 (01) 185-205 , vii
10 Sirotti S, Scanu A, Pascart T. et al. Calcium pyrophosphate crystal formation and deposition: where do we stand and what does the future hold?. Curr Rheumatol Rep 2024; 26 (10) 354-365
11 Tedeschi SK, Becce F, Pascart T. et al. Imaging features of calcium pyrophosphate deposition disease: consensus definitions from an international multidisciplinary working group. Arthritis Care Res (Hoboken) 2023; 75 (04) 825-834
12 Abhishek A, Doherty M. Pathophysiology of articular chondrocalcinosis—role of ANKH. Nat Rev Rheumatol 2011; 7 (02) 96-104
13 Hornung V, Bauernfeind F, Halle A. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008; 9 (08) 847-856
14 Zhang Y, Johnson K, Russell RGG. et al. Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5′-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate. Arthritis Rheum 2005; 52 (04) 1110-1117
15 Williams CJ, Qazi U, Bernstein M. et al. Mutations in osteoprotegerin account for the CCAL1 locus in calcium pyrophosphate deposition disease. Osteoarthritis Cartilage 2018; 26 (06) 797-806
16 Neogi T, Nevitt M, Niu J. et al. Lack of association between chondrocalcinosis and increased risk of cartilage loss in knees with osteoarthritis: results of two prospective longitudinal magnetic resonance imaging studies. Arthritis Rheum 2006; 54 (06) 1822-1828
17 Ibad HA, Kwee RM, Ghotbi E, Roemer FW, Guermazi A, Demehri S. Radiographically detectable intra-articular mineralization: predictor of knee osteoarthritis outcomes or only an indicator of aging? A brief report from the osteoarthritis initiative. Osteoarthr Cartil Open 2023; 5 (02) 100348
18 Abhishek A, Doherty S, Maciewicz RA, Muir K, Zhang W, Doherty M. Does chondrocalcinosis associate with a distinct radiographic phenotype of osteoarthritis in knees and hips? a case-control study. Arthritis Care Res (Hoboken) 2016; 68 (02) 211-216
19 Checa A, Chun W. Rates of meniscal tearing in patients with chondrocalcinosis. Clin Rheumatol 2015; 34 (03) 573-577
20 Chotard E, Blanchard A, Ostertag A. et al. Calcium pyrophosphate crystal deposition in a cohort of 57 patients with Gitelman syndrome. Rheumatology (Oxford) 2022; 61 (06) 2494-2503
21 Miksanek J, Rosenthal AK. Imaging of calcium pyrophosphate deposition disease. Curr Rheumatol Rep 2015; 17 (03) 20
22 Dirim B, Resnick D, Abreu M, Wangwinyuvirat M, Trudell DJ, Haghighi P. Relationship between the degeneration of the cruciate ligaments and calcium pyrophosphate dihydrate crystal deposition: anatomic, radiologic study with histologic correlation. Clin Imaging 2013; 37 (02) 342-347
23 O'Connor PJ. Crystal deposition disease and psoriatic arthritis. Semin Musculoskelet Radiol 2013; 17 (01) 74-79
24 Wu J, Wei L, Zhong J. CT imaging features of calcium pyrophosphate dihydrate crystal deposition involving spine. Journal of Radiation Research and Applied Sciences. 2024; 17 (02) 100882
25 Li B, Singer NG, Yeni YN. et al. A point-of-care Raman spectroscopy-based device for the diagnosis of gout and pseudogout: comparison with the clinical standard microscopy. Arthritis Rheumatol 2016; 68 (07) 1751-1757
26 Andrés M, Vela P, Jovaní V, Pascual E. Most needle-shaped calcium pyrophosphate crystals lack birefringence. Rheumatology (Oxford) 2019; 58 (06) 1095-1098
27 Reijnierse M, Schwabl C, Klauser A. Imaging of crystal disorders: calcium pyrophosphate dihydrate crystal deposition disease, calcium hydroxyapatite crystal deposition disease and gout pathophysiology, imaging, and diagnosis. Radiol Clin North Am 2022; 60 (04) 641-656
28 Cipolletta E, Abhishek A, Di Matteo A, Grassi W, Filippucci E. Dynamic assessment of the double contour sign by ultrasonography helps to distinguish between gout and calcium pyrophosphate deposition disease. RMD Open 2023; 9 (01) e002940
29 Cipolletta E, Moscioni E, Sirotti S. et al. Diagnosis of calcium pyrophosphate crystal deposition disease by ultrasonography: how many and which sites should be scanned?. Rheumatology (Oxford) 2024; 63 (08) 2205-2212
30 Filippou G, Scirè CA, Damjanov N. et al. Definition and reliability assessment of elementary ultrasonographic findings in calcium pyrophosphate deposition disease: a study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force. J Rheumatol 2017; 44 (11) 1744-1749
31 Tedeschi SK, Hayashi K, Rosenthal A. et al. Fractures in patients with acute calcium pyrophosphate crystal arthritis versus matched comparators in a large cohort study. Arthritis Rheumatol 2024; 76 (06) 936-941
32 Kravchenko D, Karakostas P, Kuetting D. et al. The role of dual energy computed tomography in the differentiation of acute gout flares and acute calcium pyrophosphate crystal arthritis. Clin Rheumatol 2022; 41 (01) 223-233
33 Tedeschi SK, Solomon DH, Yoshida K, Vanni K, Suh DH, Smith SE. A prospective study of dual-energy CT scanning, US and X-ray in acute calcium pyrophosphate crystal arthritis. Rheumatology (Oxford) 2020; 59 (04) 900-903
34 Tanikawa H, Ogawa R, Okuma K. et al. Detection of calcium pyrophosphate dihydrate crystals in knee meniscus by dual-energy computed tomography. J Orthop Surg Res 2018; 13 (01) 73
35 Pascart T, Norberciak L, Legrand J, Becce F, Budzik JF. Dual-energy computed tomography in calcium pyrophosphate deposition: initial clinical experience. Osteoarthritis Cartilage 2019; 27 (09) 1309-1314
36 Abreu M, Johnson K, Chung CB. et al. Calcification in calcium pyrophosphate dihydrate (CPPD) crystalline deposits in the knee: anatomic, radiographic, MR imaging, and histologic study in cadavers. Skeletal Radiol 2004; 33 (07) 392-398
37 Watura C, Saifuddin A. Tophaceous calcium pyrophosphate dihydrate deposition disease of the knee mimicking an aggressive soft tissue tumour. BMJ Case Rep 2014; 2014: bcr2014203998
38 Chan L, Chan C, Wong F. Calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint. Hong Kong J Radiol. 2013; 16 (02) e9-e12
39 Cowley S, McCarthy G. Diagnosis and treatment of calcium pyrophosphate deposition (CPPD) disease: a review. Open Access Rheumatol 2023; 15: 33-41
40 Shi J, Ermann J, Weissman BN, Smith SE, Mandell JC. Thinking beyond pannus: a review of retro-odontoid pseudotumor due to rheumatoid and non-rheumatoid etiologies. Skeletal Radiol 2019; 48 (10) 1511-1523
41 Kaushik S, Erickson JK, Palmer WE, Winalski CS, Kilpatrick SJ, Weissman BN. Effect of chondrocalcinosis on the MR imaging of knee menisci. AJR Am J Roentgenol 2001; 177 (04) 905-909
42 Zhang W, Doherty M, Pascual E. et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis 2011; 70 (04) 571-575
43 Pascart T, Robinet P, Ottaviani S. et al. Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial. Lancet Rheumatol 2023; 5 (09) e523-e531
44 Damart J, Filippou G, Andrès M. et al. Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritis. Rheumatology (Oxford) 2024; 63 (02) 446-455
45 Finckh A, Mc Carthy GM, Madigan A. et al. Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial. Arthritis Res Ther 2014; 16 (05) 458
46 Cipolletta E, Di Matteo A, Scanu A. et al. Biologics in the treatment of calcium pyrophosphate deposition disease: a systematic literature review. Clin Exp Rheumatol 2020; 38 (05) 1001-1007
47 Iwasaki K, Nakamura T, Shin S, Nakagawa T, Itouda K, Tsuchiya K. Calcium pyrophosphate deposition disease after total knee arthroplasty: Comparison with periprosthetic joint infection. J Orthop 2019; 16 (02) 128-132
48 Abhishek A, Tedeschi SK, Pascart T. et al. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease. Arthritis Rheumatol 2023; 75 (10) 1703-1713
49 Painter CF. Subdeltoid bursitis. Boston Med Surg J 1907; 156 (12) 345-349
50 Harvie P, Pollard TCB, Carr AJ. Calcific tendinitis: natural history and association with endocrine disorders. J Shoulder Elbow Surg 2007; 16 (02) 169-173
51 Louwerens JKG, Sierevelt IN, van Hove RP, van den Bekerom MPJ, van Noort A. Prevalence of calcific deposits within the rotator cuff tendons in adults with and without subacromial pain syndrome: clinical and radiologic analysis of 1219 patients. J Shoulder Elbow Surg 2015; 24 (10) 1588-1593
52 Hurt G, Baker Jr CL. Calcific tendinitis of the shoulder. Orthop Clin North Am 2003; 34 (04) 567-575
53 Hegazi T. Hydroxyapatite deposition disease: a comprehensive review of pathogenesis, radiological findings, and treatment strategies. Diagnostics (Basel) 2023; 13 (16) 2678
54 Sengar DP, McKendry RJ, Uhthoff HK. Increased frequency of HLA-A1 in calcifying tendinitis. Tissue Antigens 1987; 29 (03) 173-174
55 Paik NC. Acute calcific tendinitis of the gluteus medius: an uncommon source for back, buttock, and thigh pain. Semin Arthritis Rheum 2014; 43 (06) 824-829
56 Faure G, Daculsi G. Calcified tendinitis: a review. Ann Rheum Dis 1983; 42 (Suppl. 01) 49-53
57 McCarty DJ, Halverson PB, Carrera GF, Brewer BJ, Kozin F. “Milwaukee shoulder”—association of microspheroids containing hydroxyapatite crystals, active collagenase, and neutral protease with rotator cuff defects. I. Clinical aspects. Arthritis Rheum 1981; 24 (03) 464-473
58 Rui YF, Lui PP, Chan LS, Chan KM, Fu SC, Li G. Does erroneous differentiation of tendon-derived stem cells contribute to the pathogenesis of calcifying tendinopathy?. Chin Med J (Engl) 2011; 124 (04) 606-610
59 Uhthoff HK, Loehr JW. Calcific tendinopathy of the rotator cuff: pathogenesis, diagnosis, and management. J Am Acad Orthop Surg 1997; 5 (04) 183-191
60 Codman EA. The Shoulder: Rupture of the Supraspinatus Tendon and Other Lesions In or About the Subacromial Bursa. Schaumberg, IL: ASES Foundation;
61 Benjamin M, Rufai A, Ralphs JR. The mechanism of formation of bony spurs (enthesophytes) in the Achilles tendon. Arthritis Rheum 2000; 43 (03) 576-583
62 Girl RY, Hwan KY, Song PM. Arthroscopic treatment in calcific tendinitis of the shoulder. Clin Shoulder Elbow 2000; 3 (02) 68-74
63 Kapoor T, Kapoor A, Kapoor A, Kapoor A, Kapoor R. Hydroxyapatite deposition disease—think beyond the shoulder!! A case series with unusual sites of involvement. Indian J Musculoskelet Radiol. 2023; 5 (01) 35-39
64 Boardman J, Kanal E, Aldred P, Boonsiri J, Nworgu C, Zhang F. Frequency of acute longus colli tendinitis on CT examinations. Emerg Radiol 2017; 24 (06) 645-651
65 Offiah CE, Hall E. Acute calcific tendinitis of the longus colli muscle: spectrum of CT appearances and anatomical correlation. Br J Radiol 2009; 82 (978) e117-e121
66 Moyer RA, Bush DC, Harrington TM. Acute calcific tendinitis of the hand and wrist: a report of 12 cases and a review of the literature. J Rheumatol 1989; 16 (02) 198-202
67 Fam AG, Rubenstein J. Hydroxyapatite pseudopodagra. a syndrome of young women. Arthritis Rheum 1989; 32 (06) 741-747
68 Kraemer EJ, El-Khoury GY. Atypical calcific tendinitis with cortical erosions. Skeletal Radiol 2000; 29 (12) 690-696
69 Halverson PB, McCarty DJ, Cheung HS, Ryan LM. Milwaukee shoulder syndrome: eleven additional cases with involvement of the knee in seven (basic calcium phosphate crystal deposition disease). Semin Arthritis Rheum 1984; 14 (01) 36-44
70 Genta Marcia S, Gabay C. Images in clinical medicine. Milwaukee shoulder. N Engl J Med 2006; 354 (02) e2
71 Zubler C, Mengiardi B, Schmid MR, Hodler J, Jost B, Pfirrmann CWA. MR arthrography in calcific tendinitis of the shoulder: diagnostic performance and pitfalls. Eur Radiol 2007; 17 (06) 1603-1610
72 Freire V, Moser TP, Lepage-Saucier M. Radiological identification and analysis of soft tissue musculoskeletal calcifications. Insights Imaging 2018; 9 (04) 477-492
73 Paul H, Reginato AJ, Schumacher HR. Alizarin red S staining as a screening test to detect calcium compounds in synovial fluid. Arthritis Rheum 1983; 26 (02) 191-200
74 Ring D, Vaccaro AR, Scuderi G, Pathria MN, Garfin SR. Acute calcific retropharyngeal tendinitis. Clinical presentation and pathological characterization. J Bone Joint Surg Am 1994; 76 (11) 1636-1642
75 Olsen KM, Chew FS. Tumoral calcinosis: pearls, polemics, and alternative possibilities. Radiographics 2006; 26 (03) 871-885
76 Oliva F, Via AG, Maffulli N. Calcific tendinopathy of the rotator cuff tendons. Sports Med Arthrosc Rev 2011; 19 (03) 237-243
77 Moosmayer S, Ekeberg OM, Hallgren HB. et al. Ultrasound guided lavage with corticosteroid injection versus sham lavage with and without corticosteroid injection for calcific tendinopathy of shoulder: randomised double blinded multi-arm study. BMJ 2023; 383: e076447
78 Arirachakaran A, Boonard M, Yamaphai S, Prommahachai A, Kesprayura S, Kongtharvonskul J. Extracorporeal shock wave therapy, ultrasound-guided percutaneous lavage, corticosteroid injection and combined treatment for the treatment of rotator cuff calcific tendinopathy: a network meta-analysis of RCTs. Eur J Orthop Surg Traumatol 2017; 27 (03) 381-390
79 Oliva F, Via AG, Maffulli N. Physiopathology of intratendinous calcific deposition. BMC Med 2012; 10 (01) 95
80 Porcellini G, Paladini P, Campi F, Paganelli M. Arthroscopic treatment of calcifying tendinitis of the shoulder: clinical and ultrasonographic follow-up findings at two to five years. J Shoulder Elbow Surg 2004; 13 (05) 503-508

Supplementary Material

Supplementary Material